MedCity News July 23, 2024
Abiologics develops biologic drugs from building blocks not found in nature, which it says confers these proteins with properties that make for better medicines. Founded by Flagship Pioneering, the startup is focusing on developing novel biologic treatments for cancer and immunology.
Biologic drugs are well established treatments for a wide range of disorders, and many of these medicines have become blockbuster products. But currently available biologics still have limitations, says Avak Kahvejian, CEO co-founder of startup Abiologics. These large molecules are made for injectable, not oral dosing. Those injections are frequent. Furthermore, biologics come with the risk of dangerous immune responses.
Cambridge, Massachusetts-based Abiologics is working to improve on biologic drugs by starting with the way they are designed. The...
Today's Sponsors
Today's Sponsor